UCB SA (UCB.BR)

EUR 169.2

(5.0%)

Total Liabilities Summary of UCB SA

  • UCB SA's latest annual total liabilities in 2023 was 6.56 Billion EUR , down -3.53% from previous year.
  • UCB SA's latest quarterly total liabilities in 2024 Q2 was 6.67 Billion EUR , down 0.0% from previous quarter.
  • UCB SA reported annual total liabilities of 6.8 Billion EUR in 2022, up 16.83% from previous year.
  • UCB SA reported annual total liabilities of 5.82 Billion EUR in 2021, down -3.69% from previous year.
  • UCB SA reported quarterly total liabilities of 6.56 Billion EUR for 2023 FY, down -3.53% from previous quarter.
  • UCB SA reported quarterly total liabilities of 6.34 Billion EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Total Liabilities Chart of UCB SA (2023 - 2002)

Historical Annual Total Liabilities of UCB SA (2023 - 2002)

Year Total Liabilities Total Liabilities Growth
2023 6.56 Billion EUR -3.53%
2022 6.8 Billion EUR 16.83%
2021 5.82 Billion EUR -3.69%
2020 6.04 Billion EUR 48.5%
2019 4.07 Billion EUR -4.39%
2018 4.25 Billion EUR 1.87%
2017 4.18 Billion EUR -11.7%
2016 4.73 Billion EUR -12.48%
2015 5.41 Billion EUR 2.89%
2014 5.25 Billion EUR -3.29%
2013 5.43 Billion EUR 14.05%
2012 4.76 Billion EUR 9.46%
2011 4.35 Billion EUR -0.5%
2010 4.37 Billion EUR -6.93%
2009 4.7 Billion EUR -14.6%
2008 5.5 Billion EUR 4.08%
2007 5.29 Billion EUR -7.5%
2006 5.72 Billion EUR 147.83%
2005 2.3 Billion EUR -32.29%
2004 3.4 Billion EUR 160.76%
2003 1.3 Billion EUR 23.83%
2002 1.05 Billion EUR 0.0%

Peer Total Liabilities Comparison of UCB SA

Name Total Liabilities Total Liabilities Difference
Nicox S.A. 31.56 Million EUR -20693.867%
European Medical Solutions 33.86 Million EUR -19282.271%
FERMENTALG 19.39 Million EUR -33738.54%
argenx SE 402.79 Million EUR -1529.6%
BioSenic S.A. 32.26 Million EUR -20244.657%
Celyad Oncology SA 9.97 Million EUR -65684.726%
Hyloris Pharmaceuticals SA 8.61 Million EUR -76119.229%
Onward Medical N.V. 25.69 Million EUR -25442.844%
Oxurion NV 19.73 Million EUR -33159.019%
PHAXIAM Therapeutics S.A. 25.69 Million EUR -25445.826%
Financière de Tubize SA 123.65 Million EUR -5208.526%